US Patent

US8193182 — Substituted isoquinolin-1(2H)-ones, and methods of use thereof

Composition of Matter · Assigned to Intellikine LLC · Expires 2032-09-24 · 6y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects chemical entities that modulate PI3 kinase activity and their methods of use for treating diseases and conditions associated with PI3 kinase activity.

USPTO Abstract

Chemical entities of Formula I: that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
US8193182
Jurisdiction
US
Classification
Composition of Matter
Expires
2032-09-24
Drug substance claim
Yes
Drug product claim
No
Assignee
Intellikine LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.